Ignite Creation Date:
2025-12-25 @ 2:55 AM
Ignite Modification Date:
2025-12-29 @ 12:50 PM
Study NCT ID:
NCT00779233
Status:
COMPLETED
Last Update Posted:
2008-10-24
First Post:
2008-10-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bioequivalence Study of Zidovudine 300 mg Tablets, USP Under Fasting Conditions
Sponsor:
Ranbaxy Laboratories Limited
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-09
Start Date Type:
None
Primary Completion Date:
2004-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2004-10
Completion Date Type:
ACTUAL
First Submit Date:
2008-10-23
First Submit QC Date:
None
Study First Post Date:
2008-10-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2008-10-23
Last Update Post Date:
2008-10-24
Last Update Post Date Type:
ESTIMATED